Company/Division name | Jubilant HollisterStier |
Parent company | Jubilant Pharma Limited |
Type of work | Manufacturing |
If manufacturing, is the company a contract manufacturer? | Yes |
Reshoring category: | Reshoring |
Year reshoring announced: | 2021 |
Domestically, the work will be done: | Both |
City reshored to: | Spokane |
State(s) reshored to: | WA |
If relevant, work nearshored to: | - |
Industry(ies): | Chemicals, Biopharmaceutical |
Product(s) reshored | biopharmaceuticals, COVAXIN™, COVID-19 vaccine |
What domestic positive factors made reshoring more attractive? | Impact on domestic economy, Lead time/Time to market, Under-utilized capacity, Other, import replacement, Covid-19 |